See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
3x5 Partners is a venture capital firm that collaborates with passionate entrepreneurs developing solutions to global health and climate crises. The firm's mission is to 'invest in what the world needs,' focusing on early stage companies developing solutions that significantly improve the lives of people and help humanity be better stewards of the planet. Their dual investment strategy is guided by foundational beliefs that people's and planet's health are intertwined, and represent areas where innovation is most needed. Healthcare investments include biotechnology, medical devices and diagnostic companies. The firm addresses environmental challenges through investments in companies with innovation for water, energy, food, and waste. 3x5 is committed to building companies with patient capital and believes that prioritizing what is best for the portfolio companies ultimately leads to the best outcomes for investors. With careful assembly of a high-conviction portfolio, 3x5 leads early financing rounds, aims to be an active board member, and deploys $15M-$20M per company.
Notable quotes
“Our goal has always been to significantly improve the lives of people and help humanity be better stewards of the planet. Protecting the shared health of the planet and its people is more critical than ever. We believe deeply that, far from being an encumbrance, investing in essential solutions is the source of our performance.”
“We're pleased to join American Century. Our expertise in collaborating with passionate entrepreneurs who are developing solutions in response to global healthcare and climate needs dovetails with the firm's commitment to doing well while doing good. We believe this will be a great fit as we continue our work.”
Team
Tony Arnerich
Co-Founder and Managing Director
Joe Biller
Managing Director
David Yeh
Managing Director
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Fervo Energy | Series C | $138m | 2022-08-22 |
| Kaleidoscope | Series A | — | 2023-08-08 |
| Bonum Therapeutics | Series A | — | 2022-11-15 |
| Arch Oncology | unknown | — | 2021 |
| Adarza BioSystems | unknown | — | 2021 |
| Good Therapeutics | Series A | — | 2020-05-21 |
| Intervene | unknown | — | 2021 |
| EnZinc | Seed | — | 2022-07-25 |
| Tryton Medical | Other Equity | $20m | 2014-09-09 |
| Smart Wires | unknown | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| RiverVest Venture Partners | 2 |
| Vivo Capital | 1 |
| Rally Ventures | 1 |
| DCVC | 1 |
| Canepa Advanced Healthcare Fund | 1 |
Fit check
Is 3x5 Special Opportunity Fund a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit